Rajkumar Ganesan

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Research & Development, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajkumar Ganesan. Retrieved from https://idiyas.com/inventor/rajkumar-ganesan-tm6dyvj6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rajkumar Ganesan: Innovator in Stem Cell Research

Introduction

Rajkumar Ganesan is a notable inventor recognized for his contributions to the field of stem cell research. He has made significant strides in developing materials and methods for the manufacture of pluripotent stem cells. His work is pivotal in advancing medical science and therapeutic applications.

Latest Patents

Rajkumar Ganesan holds a patent titled "Materials and Methods for the Manufacture of Pluripotent Stem Cells." This patent highlights his innovative approach to stem cell technology and its potential impact on regenerative medicine. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Ganesan is currently employed at Janssen Research & Development, LLC, where he continues to push the boundaries of scientific research. His role at this esteemed organization allows him to collaborate with other leading experts in the field, further enhancing his contributions to stem cell research.

Collaborations

Throughout his career, Rajkumar Ganesan has worked alongside notable colleagues such as Iqbal S Grewal and Sanjaya Singh. These collaborations have enriched his research and fostered a dynamic environment for innovation.

Conclusion

Rajkumar Ganesan is a distinguished inventor whose work in stem cell research is making a significant impact in the medical field. His innovative patent and collaborations with esteemed colleagues underscore his commitment to advancing science and improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…